Your browser doesn't support javascript.
loading
Milvexian, an orally bioavailable, small-molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits.
Wong, Pancras C; Crain, Earl J; Bozarth, Jeffrey M; Wu, Yiming; Dilger, Andrew K; Wexler, Ruth R; Ewing, William R; Gordon, David; Luettgen, Joseph M.
Afiliação
  • Wong PC; Cardiovascular and Fibrosis Drug Discovery Biology, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Crain EJ; Cardiovascular and Fibrosis Drug Discovery Biology, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Bozarth JM; Cardiovascular and Fibrosis Drug Discovery Biology, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Wu Y; Cardiovascular and Fibrosis Drug Discovery Biology, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Dilger AK; Cardiovascular Drug Discovery Chemistry, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Wexler RR; Cardiovascular Drug Discovery Chemistry, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Ewing WR; Cardiovascular Drug Discovery Chemistry, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Gordon D; Cardiovascular and Fibrosis Drug Discovery Biology, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Luettgen JM; Cardiovascular and Fibrosis Drug Discovery Biology, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
J Thromb Haemost ; 20(2): 399-408, 2022 02.
Article em En | MEDLINE | ID: mdl-34752670

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Trombose das Artérias Carótidas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Trombose das Artérias Carótidas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article